The efficacy and safety of anti ‐PD‐1/PD‐L1 antibodies combined with chemotherapy or CTLA4 antibody as a first‐line treatment for advanced lung cancer

This article is protected by copyright. All rights reserved.

Source: International Journal of Cancer - January 10, 2018 Category: Cancer & Oncology Authors: Xiaoling Xu, Zhiyu Huang, Lei Zheng, Yun Fan Tags: Research Article Source Type: research